Evaluation of Poly(isobutylcyanoacrylate) Nanoparticles for Mucoadhesive Ocular Drug Delivery. I. Effect of Formulation Variables on Physicochemical Characteristics of Nanoparticles

A factorial design was applied to evaluate the effect of formulation variables on physicochemical properties of poly(isobutylcyanoacrylate) nanoparticles. Formulation variables were dextran T40 or T70 and Pluronic™ F68 or Tween™ 20 acting as stabilizer and surfactant respectively, and three pH levels (2, 4 and 7). Nanoparticles possessed unimodal particle size distribution with significant effect of dextran, surfactant and pH. A wide range of molecular weight distribution was observed with significant effect of pH and dextran on average molecular weight. NMR studies revealed the presence of dextran, monomer and surfactants in the nanoparticles. Solid state surface analysis using X-ray photoelectron spectroscopy confirmed the presence of three chemical environments to the carbon envelope, O – C = O,C – O/C≡N and C – C.

[1]  H. Junginger,et al.  A Surface Energy Analysis of Mucoadhesion: Contact Angle Measurements on Polycarbophil and Pig Intestinal Mucosa in Physiologically Relevant Fluids , 2004, Pharmaceutical Research.

[2]  N. Ganguly,et al.  Predicting the Effect of Nonionic Surfactants on Dispersed Droplet Radii in Submicron Oil-in-Water Emulsions , 1992, Pharmaceutical Research.

[3]  R. Gurny,et al.  Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutylcyanoacrylate nanoparticles , 1986 .

[4]  J. Kreuter,et al.  Molecular weights of polycyanoacrylate nanoparticles , 1983 .

[5]  J. Kreuter,et al.  In vitro studies of poly(methyl methacrylate) adjuvants. , 1976, Journal of pharmaceutical sciences.

[6]  J. Kreuter,et al.  Optimization of pilocarpine loading onto nanoparticles by sorption procedures , 1986 .

[7]  S. Davis,et al.  Particle size and size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. II. Influence of stabilizers , 1985 .

[8]  S. Davis,et al.  The targeting of drugs using polymeric microspheres , 1983 .

[9]  J. Robinson,et al.  Ocular delivery of progesterone using a bioadhesive polymer , 1985 .

[10]  R. W. Wood,et al.  Ocular drug delivery of progesterone using nanoparticles. , 1986, Journal of microencapsulation.

[11]  William G. Cochran,et al.  Experimental Designs, 2nd Edition , 1950 .

[12]  S. Davis,et al.  Molecular weights of poly(butyl 2‐cyanoacrylate) produced during nanoparticle formation , 1985 .

[13]  Bernard J. Ryan,et al.  Water effects on the zwitterionic polymerization of cyanoacrylates , 1989 .

[14]  M. A. Khan,et al.  Evaluation of carrier capacity and release characteristics for poly( butyl 2-cyanoacrylate) nanoparticles , 1986 .

[15]  H. Junginger,et al.  Visualization studies of the mucoadhesive interface , 1992 .

[16]  A. Zimmer,et al.  Studies on the transport pathway of PBCA nanoparticles in ocular tissues. , 1991, Journal of microencapsulation.

[17]  J. W. Goodwin,et al.  The preparation and characterisation of polymer latices formed in the absence of surface active agents , 1973 .

[18]  P. Couvreur,et al.  Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutylcyanoacrylate nanoparticle preparations , 1990 .

[19]  H. Fessi,et al.  Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules , 1986 .

[20]  G. Birrenbach,et al.  Polymerized micelles and their use as adjuvants in immunology. , 1976, Journal of pharmaceutical sciences.

[21]  S. Davis,et al.  Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles: I. Influence of physicochemical factors , 1984 .

[22]  A. Mitra,et al.  Overview of ocular drug delivery and iatrogenic ocular cytopathologies , 1993 .

[23]  R. W. Wood,et al.  Ocular disposition of poly-hexyl-2-cyano[3-14C]acrylate nanoparticles in the albino rabbit , 1985 .

[24]  P. Couvreur.  Polyalkylcyanoacrylates as colloidal drug carriers. , 1988, Critical reviews in therapeutic drug carrier systems.